Supernus Pharmaceuticals Inc (SUPN)
32.02
-0.08
(-0.25%)
USD |
NASDAQ |
Oct 04, 16:00
32.00
-0.02
(-0.08%)
After-Hours: 20:00
Supernus Pharmaceuticals Shareholders Equity (Annual): 921.52M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 921.52M |
| December 31, 2022 | 886.20M |
| December 31, 2021 | 815.85M |
| December 31, 2020 | 744.86M |
| December 31, 2019 | 595.43M |
| December 31, 2018 | 453.02M |
| December 31, 2017 | 267.48M |
| December 31, 2016 | 191.76M |
| Date | Value |
|---|---|
| December 31, 2015 | 88.01M |
| December 31, 2014 | 40.70M |
| December 31, 2013 | 33.46M |
| December 31, 2012 | 57.57M |
| December 31, 2011 | 9.443M |
| December 31, 2010 | -44.32M |
| December 31, 2009 | -6.156M |
| December 31, 2008 | -6.747M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
595.43M
Minimum
2019
921.52M
Maximum
2023
792.77M
Average
815.85M
Median
2021
Shareholders Equity (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 431.76M |
| Regeneron Pharmaceuticals Inc | 25.97B |
| United Therapeutics Corp | 5.985B |
| Ligand Pharmaceuticals Inc | 700.91M |
| Myomo Inc | 8.989M |